Celltrion Pharm

068760.KQ

37.13 USD

-1.03

-2.70%

Overview

Last close

37.13 usd

Market cap

1.54B usd

52 week high

93.83 usd

52 week low

33.02 usd

Target price

94.56 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

8.4949

Price/Book Value

6.0959

Enterprise Value

1.74B usd

EV/Revenue

5.727

EV/EBITDA

49.3843

Key financials

Revenue TTM

191.01M usd

Gross Profit TTM

50.71M usd

EBITDA TTM

29.75M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

463.19M usd

Net debt

N/A usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.